Cosmo NVCMOPF +4.87%82 Median PS Value is $122.56 as of Jun. 25, 2026, which is 13368% above its 10-year median of 0.91. GuruFocus rates CMOPF with a GF Score™ of 82/100 and a GF Value™ of $54.86 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 544 Drug Manufacturers companies, Cosmo NV ranks better than 67.46% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cosmo NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $7.581. Cosmo NV's 10-Year median PS Ratio is 16.1667. Therefore, the Median PS Value for today is $122.56.
As of today (2026-06-25), Cosmo NV's share price is $85.45. Cosmo NV's Median PS Value is $122.56. Therefore, Cosmo NV's Price to Median PS Value for today is 0.70.
The historical rank and industry rank for Cosmo NV's Median PS Value or its related term are showing as below:
CMOPF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.23 Med: 0.91 Max: 3.75
Current: 0.7
During the past 13 years, the highest Price to Median PS Value of Cosmo NV was 3.75. The lowest was 0.23. And the median was 0.91.
CMOPF's Price-to-Median-PS-Value is ranked better than 67.46% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.84
vs CMOPF: 0.70
Cosmo NV (OTCPK:CMOPF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Cosmo NV's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
85.45
/
122.56
=
0.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmo NV Median PS Value Related Terms
Cosmo NV Median PS Value Historical Data
* Premium members only.
The historical data trend for Cosmo NV's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CMOPF vs LLY, JNJ, ABBV: Median PS Value Comparison
For the Drug Manufacturers - General subindustry, Cosmo NV's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmo NV Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cosmo NV's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Cosmo NV's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 16.1667.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cosmo NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $7.581.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmo NV (CMOPF) has a Median PS Value of $122.56 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cosmo NV and its competitors. This is 13368% above median its historical median of 0.91. Over the past decade, Cosmo NV's Median PS Value has ranged from 0.23 to 3.75. According to the industry distribution chart, Cosmo NV ranks #177 out of 544 companies in the Drug Manufacturers industry, placing it in the top 32.5%.
Is Cosmo NV's Median PS Value too high?
Cosmo NV's current Median PS Value of $122.56 is 13368% above median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 3.75. The Drug Manufacturers industry median Median PS Value is 0.84. Cosmo NV's value of $122.56 is 14490.5% above this industry median. Based on the distribution chart, Cosmo NV ranks #177 out of 544 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Cosmo NV has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmo NV's Median PS Value compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Cosmo NV ranks #177 out of 544 companies for Median PS Value. This puts Cosmo NV in the upper half of its industry. The industry median Median PS Value is 0.84. Cosmo NV's value of $122.56 is 14490.5% above this benchmark. Historically, Cosmo NV's own Median PS Value has ranged from 0.23 to 3.75 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 0.84, Cosmo NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmo NV's current Median PS Value of $122.56 is 14490.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cosmo NV and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmo NV's current Median PS Value is $122.56, which is 13368% above median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo NV stock overvalued right now?
Based on GuruFocus' analysis, Cosmo NV (CMOPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $54.86, compared to a current price of $85.45 — trading 55.8% above its estimated fair value. The current Median PS Value is $122.56, which is 13368% above median its 10-year median of 0.91 and 14490.5% above the Drug Manufacturers industry median of 0.84. Cosmo NV's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Cosmo NV (CMOPF), the current Median PS Value is $122.56 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmo NV (CMOPF) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued.
The current stock price of $85.45 is trading 55.8% above its estimated GF Value™ of $54.86.
GuruFocus considers Cosmo NV to be Significantly Overvalued.
Key valuation signals for CMOPF:
Median PS Value: $122.56 (13368% above median its 10-year median of 0.91)
GF Value™: $54.86 vs. price of $85.45 (55.8% above fair value)
Industry Position: 14490.5% above the Drug Manufacturers median (#177 of 544)
No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
82GF Score
Get the complete analysis for CMOPF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMOPF has been successfully added to your 
